Catalyst Pharmaceuticals (CPRX) Non-cash Items (2013 - 2025)

Catalyst Pharmaceuticals (CPRX) reported Non-cash Items of $7.1 million for Q4 2025, down 2.99% on a YoY basis from $7.4 million in Q4 2024, and down 2.99% quarter-over-quarter from $7.4 million in Q4 2024.

Catalyst Pharmaceuticals (CPRX) Non-cash Items (2013 - 2025) Analysis & Trends

Catalyst Pharmaceuticals has reported Non-cash Items for 8 years, with the latest figure at $7.1 million in Q4 2025.

  • For the quarter ending Q4 2025, Non-cash Items fell 2.99% year-over-year to $7.1 million; the trailing twelve-month figure through Dec 2025 stood at $7.1 million (down 2.99% YoY), and the FY2025 full-year result was $7.1 million, down 2.99% from the prior year.
  • Non-cash Items for Q4 2025 stood at $7.1 million, down from $7.4 million in the prior quarter.
  • The five-year high for Non-cash Items was $7.4 million in Q4 2024, with the low at $7.1 million in Q4 2025.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Catalyst Pharmaceuticals 3.84 Bn 3.08 Bn 134.92 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 7.13 Mn
Dec 31, 2025 7.13 Mn
Dec 31, 2024 7.35 Mn
Dec 31, 2024 7.35 Mn
Dec 31, 2018 4.35 Mn
Dec 31, 2018 4.35 Mn
Sep 30, 2018 4.01 Mn
Sep 30, 2018 4.01 Mn
Jun 30, 2018 4.10 Mn
Jun 30, 2018 4.10 Mn
Mar 31, 2018 3.62 Mn
Mar 31, 2018 3.62 Mn
Dec 31, 2017 2.91 Mn
Dec 31, 2017 2.91 Mn
Sep 30, 2017 3.50 Mn
Sep 30, 2017 3.50 Mn
Jun 30, 2017 3.24 Mn
Jun 30, 2017 3.24 Mn
Mar 31, 2017 2.64 Mn
Mar 31, 2017 2.64 Mn